Resumo

FREZA DOMINGUEZ, Jesús Alberto. Analgesia Obstétrica Sistémica con Remifentanilo y Dexmedetomidina.. Anest Analg Reanim [online]. 2014, vol.27, n.2, pp.5-5. ISSN 1688-1273.

For all women in labor and childbirth are painful experiences, in addition to that, fear and anxiety can increase it and hinder its management. Also pain during labor is equated with pain after surgery, without forgetting also the attention of labor is a medical procedure of high value and prevalence worldwide. In obstetric analgesia the gold standard is the regional technique but when this is contraindicated or refused by the patient, usually you decide to leave analgesia and further labor pain, although there is enough information that the proper approach to pain decreases maternal-fetal morbidity and mortality, in addition to improvements obtained in a cost-effective shortening the length of hospital stay and impacting positively on patients economy. The use of sedatives and narcotics in the patient in labor has always been controversial as these drugs tend to cross the uteroplacental barrier and can have adverse effects on the neonate. But the newer drugs such as remifentanil and dexmedetomidine because of their pharmacokinetic properties do not cross the placenta so significantly further literature refers that dexmedetomidine does not pass into the fetal circulation. One more reason to value which can be used in conjunction remifentanil for analgesia in labor and thereby obtain better pain management, better state of comfort, and hemodynamics in obstetric patients and that it is mandatory to provide the best possible care and attention to both the mother and the neonate.

Palavras-chave : remifentanil; dexmedetomidine; systemic obstetric analgesia; obstetric anesthesia and analgesia.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )